Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when FRST files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: FRST Primis Financial Corp. 8-K

Primis Financial director Allen R. Jones, Jr. resigns from board effective Aug 31, 2026

Filed August 31, 2026 · Period ending August 28, 2026 · ~1 min read

4 key changes 1 section

Key Changes

  • low

    Dr. Allen R. Jones, Jr. notified the board of his intention to resign as a director, effective August 31, 2026.

  • low

    The resignation was not the result of any dispute or disagreement with the Company or its board.

  • low

    Upon the resignation, the board size will be reduced from eleven to ten directors.

  • low

    Dr. Jones was a member of the Enterprise Risk Committee and will also resign from that committee.

Summary

Primis Financial Corp. disclosed that director Allen R. Jones, Jr. has resigned from the board, effective August 31, 2026. The filing states the resignation was not due to any dispute or disagreement with the company or its board. Following his departure, the board will consist of ten directors, down from eleven. Dr. Jones also served on the Enterprise Risk Committee and will step down from that role as well.

The filing does not indicate a replacement or any impact on committee composition. This is a routine governance change with no stated business impact.

Section-by-Section Diff

Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation

~200 words

Director Allen R. Jones, Jr. resigns from Primis Financial's board effective Aug 31, 2026, reducing board size to ten.

2 Added
Show 2 minor / wording changes
Added Board size reduction low

Added in current filing · verify on EDGAR →

Effective upon Dr. Jones’ resignation as a director, the size of the Company’s Board of Directors will be reduced from eleven to ten directors.

The board will shrink from eleven to ten directors upon Dr. Jones' resignation. This is a routine governance change with no stated business impact.

Added Committee membership low

Added in current filing · verify on EDGAR →

At the time of his resignation, Dr. Jones was a member of the Enterprise Risk Committee and as a result, will also be resigning as a member of the Enterprise Risk Committee.

Dr. Jones was a member of the Enterprise Risk Committee and will also resign from that committee. The filing does not disclose a replacement or any impact on committee composition.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify